Sagimet Biosciences (SGMT) Cash & Equivalents (2023 - 2024)
Historic Cash & Equivalents for Sagimet Biosciences (SGMT) over the last 2 years, with Q3 2024 value amounting to $77.0 million.
- Sagimet Biosciences' Cash & Equivalents fell 2437.89% to $77.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $77.0 million, marking a year-over-year decrease of 2437.89%. This contributed to the annual value of $75.1 million for FY2023, which is N/A changed from last year.
- As of Q3 2024, Sagimet Biosciences' Cash & Equivalents stood at $77.0 million, which was down 2437.89% from $96.0 million recorded in Q2 2024.
- Sagimet Biosciences' 5-year Cash & Equivalents high stood at $176.8 million for Q1 2024, and its period low was $18.5 million during Q2 2023.